News | August 23, 2024
Sun Pharma introduces STARIZO in India for skin infections
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
The emergence of new infections in India is a growing concern
This two-day program was attended by 40 doctors & paramedical staff
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Our centers are performing as expected or even better
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Subscribe To Our Newsletter & Stay Updated
